GLP-1 receptor agonists have been prescribed for type 2 diabetes since the mid-2000s, giving us nearly two decades of safety data
In fact, starting early helps you build healthy habits from day one so your body stays strong and nourished as your appetite adjusts
Based on these retrospective analyses, one could argue that all newly diagnosed, as well as established, type 2 diabetes patients should be started simultaneously, within a few weeks to months, on an SGLT2 inhibitor plus a GLP-1 receptor agonist
It is important to monitor for harmful side effects such as high blood pressure, rapid heart rate, or loss of appetite
In the Novo case, he highlighted internal company statements that Novo had deliberately limited starter doses to avoid running out of higher maintenance doses later
Finally, if weight loss is a significant goal for you, seek out a program specifically designed for it